Select Bibliography

Filter by any of these (after searching):

Bao, Riyue

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Bao, Riyue , Surriga, Oliver , Olson, Daniel J. , Allred, Jacob B. ... - - Melanoma Res - 2021

Manuscript - Secondary-not-in-original - Primary - Experimental - A091201

Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)

Luke, Jason J. , Olson, Daniel J. , Allred, Jacob B. ... - - Clin. Cancer Res. - 2020

Manuscript - Primary - Primary - Experimental - A091201

Correlates of overall survival (OS) in metastatic vs. primary uveal melanoma (UM) and results of a randomized trial of cabozantinib (cabo) vs. chemotherapy (chemo) Alliance A091201

Olson, Daniel J. , Bao, Riyue , Allred, Jacob B. , Strand, Carrie A. ... - ASCO - J Clin Oncol - 2019

Abstract - Secondary - Primary - Experimental - A091201